{"data":[{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":666022,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":666022,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":666022,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001214659-26-006495","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000093751-26-000201","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"ALTIMMUNE INC","ticker":"ALT","cusip":"02155H200","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":7145550,"percentOfClass":5.5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001193125-26-201587","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":20000000,"percentOfClass":9.8,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":13400000,"percentOfClass":6.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":13400000,"percentOfClass":6.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":13400000,"percentOfClass":6.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":13400000,"percentOfClass":6.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001346824-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":13000000,"percentOfClass":6.5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001346824-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":13000000,"percentOfClass":6.5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001346824-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":13000000,"percentOfClass":6.5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001346824-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":13000000,"percentOfClass":6.5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001193125-26-201587","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":10000000,"percentOfClass":5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001193125-26-201587","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":10000000,"percentOfClass":5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001193125-26-201587","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10000000,"percentOfClass":5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001193125-26-201587","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10000000,"percentOfClass":5,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":9380000,"percentOfClass":4.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":9380000,"percentOfClass":4.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":9380000,"percentOfClass":4.7,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Vintage IV (Aggregator) LP","reportingCik":null,"personType":"PN","sharesOwned":4020000,"percentOfClass":2,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Vintage IV Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4020000,"percentOfClass":2,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000905148-26-002008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-24","reportingPerson":"Viking Global Opportunities Vintage IV GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4020000,"percentOfClass":2,"filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001172661-26-001579","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-04-23","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":19417221,"percentOfClass":9.99,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001172661-26-001579","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-04-23","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":19417221,"percentOfClass":9.99,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001172661-26-001579","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-04-23","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":16828258,"percentOfClass":8.65,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0001172661-26-001579","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001326190","issuerName":"Altimmune, Inc.","ticker":"ALT","cusip":"02155H200","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-04-23","reportingPerson":"Deep Track Special Opportunities Fund, LP.","reportingCik":null,"personType":"PN","sharesOwned":2588963,"percentOfClass":1.33,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000102909-26-000549","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001326190","issuerName":"Altimmune Inc","ticker":"ALT","cusip":"02155H200","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/alt"},{"accessionNo":"0000102909-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001326190","issuerName":"Altimmune Inc","ticker":"ALT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":9491159,"percentOfClass":9.09,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/alt"}],"updatedAt":"2026-11-04T07:00:16.702Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/alt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}